<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="361">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02133235</url>
  </required_header>
  <id_info>
    <org_study_id>201212175RINC</org_study_id>
    <nct_id>NCT02133235</nct_id>
  </id_info>
  <brief_title>The Need of Fiberoptic Bronchoscopy for Placing an Endobronchial Blocker</brief_title>
  <official_title>The Need and the Effectiveness of Fiberoptic Bronchoscopy for Better Lung Collapse in Vedio-assisted Thoracic Operations Using Endobronchial Blockers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <authority>Taiwan: Department of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The need of fiberoptic bronchoscopy for placing an endobronchial blocker. Endobronchial
      blockers (EBB) have been presented effective and safe alternative for lung separation in
      vedio-assisted thoracoscopic (VATS) operations. In this study, the investigators will
      randomize the patients receiving VATS operation with EBB into two groups: one group will
      receive the conventional bronchoscopic guided EBBs placement, the other group receive two
      step procedure without confirmation by fiberoptic bronchoscopy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The need of fiberoptic bronchoscopy for placing an endobronchial blocker. Endobronchial
      blockers (EBB) have been presented effective and safe alternative for lung separation in
      vedio-assisted thoracoscopic (VATS) operations. However, there were previous reports showed
      that it takes longer time to position the EBB versus the double lumen tubes. Placing EBBs
      need three-step procedure (one is placing an endotracheal tube, the second is inserting the
      EBB, the third is confirmation of the position by fiberoptic bronchoscopy). In this study,
      the investigators will randomize the patients receiving VATS operation with EBB into two
      groups: one group will receive the conventional 3-step procedure, the other group receive
      two step procedure without confirmation by fiberoptic bronchoscopy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor)</study_design>
  <primary_outcome>
    <measure>Surgical Grading for Lung Isolation</measure>
    <time_frame>10-15 minutes</time_frame>
    <safety_issue>No</safety_issue>
    <description>A: Optimal; B: Lung distension; C: Poor endobronchial blocker placement</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time Required for Proper Placement of the Endobronchial Blocker</measure>
    <time_frame>10-15 minutes</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">112</enrollment>
  <condition>Neoplasms, Pulmonary</condition>
  <condition>Thoracic Diseases</condition>
  <arm_group>
    <arm_group_label>conventional</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>insertion of endobronchial blocker and auscultation, fiberoptic confirmation and reposition</description>
  </arm_group>
  <arm_group>
    <arm_group_label>auscultation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>insertion endobronchial blocker by auscultation without conventional bronchoscopic reposition</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>conventional</intervention_name>
    <description>insertion endobronchial blocker with the guidance of fiberoptic bronchoscopy</description>
    <arm_group_label>conventional</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>auscultation</intervention_name>
    <description>insertion endobronchial blocker by auscultation, without the guidance of fiberoptic bronchoscopy</description>
    <arm_group_label>auscultation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

        Lung separation by endobronchial blockers

        Exclusion criteria:

        Lung separation by conventional double lumen tube Lung separation with endobronchial
        blockers through
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ya-Jung Cheng</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Taiwan University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>100</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <lastchanged_date>October 20, 2015</lastchanged_date>
  <firstreceived_date>April 28, 2014</firstreceived_date>
  <firstreceived_results_date>June 30, 2015</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>endobronchial blocker</keyword>
  <keyword>lung separation</keyword>
  <keyword>vedio-assisted thoracic operation</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Thoracic Diseases</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Conventional Fiberoptic Brochoscopy Group</title>
          <description>patients receiving VATS operations with endobronchial blockers with procedures: endotracheal intubation, insertion of endobronchial blocker and auscultation, fiberoptic confirmation and reposition</description>
        </group>
        <group group_id="P2">
          <title>Auscultation Group</title>
          <description>patients receiving vedio-assisted thoracic operations by endobronchial blocker with procedures: endotracheal intubation, insertion endobronchial blocker with auscultation without conventional bronchoscopic reposition</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="55"/>
                <participants group_id="P2" count="57"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="55"/>
                <participants group_id="P2" count="57"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Auscultation Group</title>
          <description>patients receiving vedio-assisted thoracic operations by endobronchial blocker with procedures: endotracheal intubation, insertion endobronchial blocker with auscultation without conventional bronchoscopic reposition</description>
        </group>
        <group group_id="B2">
          <title>Conventional Fiberoptic Brochoscopy Group</title>
          <description>patients receiving VATS operations with endobronchial blockers with procedures: endotracheal intubation, insertion of endobronchial blocker and auscultation, fiberoptic confirmation and reposition</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="57"/>
                <measurement group_id="B2" value="55"/>
                <measurement group_id="B3" value="112"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="43"/>
                <measurement group_id="B2" value="40"/>
                <measurement group_id="B3" value="83"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="14"/>
                <measurement group_id="B2" value="15"/>
                <measurement group_id="B3" value="29"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="58" lower_limit="30" upper_limit="79"/>
                <measurement group_id="B2" value="58" lower_limit="35" upper_limit="79"/>
                <measurement group_id="B3" value="58" lower_limit="30" upper_limit="79"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="30"/>
                <measurement group_id="B2" value="20"/>
                <measurement group_id="B3" value="50"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="27"/>
                <measurement group_id="B2" value="35"/>
                <measurement group_id="B3" value="62"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Taiwan</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="57"/>
                <measurement group_id="B2" value="55"/>
                <measurement group_id="B3" value="112"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Surgical Grading for Lung Isolation</title>
        <description>A: Optimal; B: Lung distension; C: Poor endobronchial blocker placement</description>
        <time_frame>10-15 minutes</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Left-sided VATS, Auscultation Group</title>
            <description>patients receiving left-sided vedio-assisted thoracic operations by endobronchial blocker with procedures: endotracheal intubation, insertion of endobronchial blocker, confirmation of endobronchial blocker position by auscultation only</description>
          </group>
          <group group_id="O2">
            <title>Left-sided VATS, Conventional Fiberoptic Brochoscopy Group</title>
            <description>patients receiving left-sided VATS operations with endobronchial blockers with procedures: endotracheal intubation, insertion of endobronchial blocker, confirmation of endobronchial blocker position by conventional fiberoptic brochoscopy group</description>
          </group>
          <group group_id="O3">
            <title>Right-sided VATS, Auscultation Group</title>
            <description>patients receiving right-sided vedio-assisted thoracic operations by endobronchial blocker with procedures: endotracheal intubation, insertion of endobronchial blocker, confirmation of endobronchial blocker position by auscultation only</description>
          </group>
          <group group_id="O4">
            <title>Right-sided VATS, Conventional Fiberoptic Bronchoscopy Group</title>
            <description>patients receiving right-sided VATS operations with endobronchial blockers with procedures: endotracheal intubation, insertion of endobronchial blocker, confirmation of endobronchial blocker position by conventional fiberoptic brochoscopy group</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="22"/>
                  <measurement group_id="O2" value="28"/>
                  <measurement group_id="O3" value="32"/>
                  <measurement group_id="O4" value="30"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Surgical Grading for Lung Isolation</title>
            <description>A: Optimal; B: Lung distension; C: Poor endobronchial blocker placement</description>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <sub_title>A: Optimal</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="12"/>
                  <measurement group_id="O2" value="13"/>
                  <measurement group_id="O3" value="15"/>
                  <measurement group_id="O4" value="14"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>B: Lung distension</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="10"/>
                  <measurement group_id="O2" value="11"/>
                  <measurement group_id="O3" value="13"/>
                  <measurement group_id="O4" value="12"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>C: Poor endobronchial blocker placement</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0"/>
                  <measurement group_id="O2" value="4"/>
                  <measurement group_id="O3" value="4"/>
                  <measurement group_id="O4" value="4"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Time Required for Proper Placement of the Endobronchial Blocker</title>
        <time_frame>10-15 minutes</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Left-sided VATS, Auscultation Group</title>
            <description>patients receiving left-sided vedio-assisted thoracic operations by endobronchial blocker with procedures: endotracheal intubation, insertion endobronchial blocker with auscultation without conventional bronchoscopic reposition</description>
          </group>
          <group group_id="O2">
            <title>Left-sided VATS, Conventional Fiberoptic Brochoscopy Group</title>
            <description>patients receiving left-sided VATS operations with endobronchial blockers with procedures: endotracheal intubation, insertion of endobronchial blocker and auscultation, fiberoptic confirmation and reposition</description>
          </group>
          <group group_id="O3">
            <title>Right-sided VATS, Auscultation Group</title>
            <description>patients receiving right-sided vedio-assisted thoracic operations by endobronchial blocker with procedures: endotracheal intubation, insertion endobronchial blocker with auscultation without conventional bronchoscopic reposition</description>
          </group>
          <group group_id="O4">
            <title>Right-sided VATS, Conventional Fiberoptic Bronchoscopy Group</title>
            <description>patients receiving right-sided VATS operations with endobronchial blockers with procedures: endotracheal intubation, insertion of endobronchial blocker and auscultation, fiberoptic confirmation and reposition</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="25"/>
                  <measurement group_id="O2" value="25"/>
                  <measurement group_id="O3" value="32"/>
                  <measurement group_id="O4" value="30"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Time Required for Proper Placement of the Endobronchial Blocker</title>
            <units>seconds</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="138.5" spread="25.5"/>
                  <measurement group_id="O2" value="130" spread="20"/>
                  <measurement group_id="O3" value="89.6" spread="9.3"/>
                  <measurement group_id="O4" value="141.1" spread="16.4"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 week</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Conventional Fiberoptic Brochoscopy Group</title>
          <description>patients receiving VATS operations with endobronchial blockers with procedures: endotracheal intubation, insertion of endobronchial blocker and auscultation, fiberoptic confirmation and reposition</description>
        </group>
        <group group_id="E2">
          <title>Auscultation Group</title>
          <description>patients receiving vedio-assisted thoracic operations by endobronchial blocker with procedures: endotracheal intubation, insertion endobronchial blocker with auscultation without conventional bronchoscopic reposition</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="57"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="57"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Failure for optimal lung isolation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="57"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>YJ Cheng</name_or_title>
      <organization>NTUH</organization>
      <phone>886-2-23123456 ext 62158</phone>
      <email>chengyj@ntu.edu.tw</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
